Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.00
+0.08 (0.62%)
At close: Apr 23, 2025, 4:00 PM
12.68
-0.32 (-2.46%)
Pre-market: Apr 24, 2025, 6:31 AM EDT
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Syndax Pharmaceuticals stock have an average target of 36.2, with a low estimate of 16 and a high estimate of 51. The average target predicts an increase of 178.46% from the current stock price of 13.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2025.
Analyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $41 | Buy | Maintains | $39 → $41 | +215.38% | Mar 20, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $39 | Buy | Maintains | $35 → $39 | +200.00% | Mar 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $42 | Strong Buy | Maintains | $45 → $42 | +223.08% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +292.31% | Mar 4, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +23.08% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
91.53M
from 23.68M
Increased by 286.51%
Revenue Next Year
202.14M
from 91.53M
Increased by 120.86%
EPS This Year
-3.94
from -3.72
EPS Next Year
-2.85
from -3.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 184.0M | 256.2M | 491.6M | ||
| Avg | 91.5M | 202.1M | 337.1M | ||
| Low | 56.2M | 128.9M | 224.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 677.0% | 179.9% | 143.2% | ||
| Avg | 286.5% | 120.9% | 66.8% | ||
| Low | 137.1% | 40.9% | 11.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.76 | -1.29 | -0.89 | ||
| Avg | -3.94 | -2.85 | -1.82 | ||
| Low | -4.56 | -3.49 | -2.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.